OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
Kondababu Kurakula, Valérie F. E. D. Smolders, Olga Tura-Ceide, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 57-57
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Vascular Inflammatory Diseases and Endothelial Phenotypes
Jenita Immanuel, Sanguk Yun
Cells (2023) Vol. 12, Iss. 12, pp. 1640-1640
Open Access | Times Cited: 40

Pulmonary Vascular Remodeling in Pulmonary Hypertension
Zhuangzhuang Jia, Shuai Wang, Haifeng Yan, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 366-366
Open Access | Times Cited: 29

Reactive Oxygen Species and Endothelial Ca2+ Signaling: Brothers in Arms or Partners in Crime?
Sharon Negri, Pawan Faris, Francesco Moccia
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9821-9821
Open Access | Times Cited: 54

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
Inés Roger, Javier Milara, Paula Montero, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4980-4980
Open Access | Times Cited: 42

Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension
Nicholas D Cober, M. Martin VandenBroek, Mark L. Ormiston, et al.
Hypertension (2022) Vol. 79, Iss. 8, pp. 1580-1590
Open Access | Times Cited: 29

Super Enhancer-Associated Circular RNA-CircKrt4 Regulates Hypoxic Pulmonary Artery Endothelial Cell Dysfunction in Mice
Cui Ma, Xiaoying Wang, Lixin Zhang, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 7, pp. 1179-1198
Closed Access | Times Cited: 21

Vascular pathobiology of pulmonary hypertension
Eunate Gallardo‐Vara, Aglaia Ntokou, Jui M. Dave, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 42, Iss. 5, pp. 544-552
Open Access | Times Cited: 26

The role of circular RNAs in pulmonary hypertension
Md Khadem Ali, Katharina Schimmel, Lan Zhao, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2200012-2200012
Open Access | Times Cited: 25

Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells
Yanjiao Jiang, Jie Huang, Yu Xia, et al.
European Journal of Pharmacology (2023) Vol. 941, pp. 175502-175502
Open Access | Times Cited: 14

Lung perfusion assessment in children with long‐COVID: A pilot study
D.A. Pizzuto, Danilo Buonsenso, Rosa Morello, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 7, pp. 2059-2067
Open Access | Times Cited: 14

Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition
Cheng Qian, Guanglu Dong, Chunmei Yang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

Integrated analysis of m6A mRNA methylation in rats with monocrotaline-induced pulmonary arterial hypertension
Yunhong Zeng, Ting Huang, Wanyun Zuo, et al.
Aging (2021) Vol. 13, Iss. 14, pp. 18238-18256
Open Access | Times Cited: 32

The contribution of endothelial cells to tissue fibrosis
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Current Opinion in Rheumatology (2023) Vol. 36, Iss. 1, pp. 52-60
Open Access | Times Cited: 12

Deep phenotyping of unaffected carriers of pathogenicBMPR2variants screened for pulmonary arterial hypertension
Eszter N. Tóth, Lucas Celant, Marili Niglas, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2400442-2400442
Open Access | Times Cited: 4

NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming
Zhibo Liu, Rongrong Zhu, Jinlong Liu, et al.
Cellular Signalling (2025), pp. 111594-111594
Closed Access

Severe COVID-19 Pneumonia, Opportunistic Candida krusei Infection, and Acute Respiratory Distress Syndrome with Pulmonary Arterial Hypertension Treated with Bosentan: A Case Report
Killen H. Briones‐Claudett, Killen H. Briones-Zamora, Jaime Galo Benites Solis, et al.
American Journal of Case Reports (2025) Vol. 26
Closed Access

Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access

Vascular HIF2 Signaling Prevents Cardiomegaly, Alveolar Congestion, and Capillary Remodeling During Chronic Hypoxia
Teresa Albendea-Gomez, Susana Mendoza-Tamajon, Rosana Castro-Mecinas, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2025)
Closed Access

Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer
Teresa C. Funk-Hilsdorf, Felix Behrens, Jana Grune, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 17

Hemin-Induced Endothelial Dysfunction and Endothelial to Mesenchymal Transition in the Pathogenesis of Pulmonary Hypertension Due to Chronic Hemolysis
Janae Gonzales, Kelsey Holbert, Kamryn Czysz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4763-4763
Open Access | Times Cited: 16

The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease
Levon M. Khachigian
Vascular Pharmacology (2023) Vol. 153, pp. 107232-107232
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top